Evidence map›Paper›PMID 18294963›Full record

ArticleFEBS letters2008

Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation.

Gary Glenn, Peter van der Geer

Open access · bronzeAbstract read
In one paragraph

Article in FEBS letters, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Receptor tyrosine kinases in the nucleus.Cold Spring Harbor perspectives in biology · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gary GlennDepartment of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182-1030, USA.
Peter van der Geer
San Diego State University · US

Funding

Directed Proteomics of Alzheimer's Related ProteinsR01AG025343 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 2004 to 2008
$1.5M
Role of Src and LRP1 in Transformation by v-SrcR01CA078629 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI VAN DER GEER, PETER · 2003 to 2007
$1.1M
ROLE IN SHC IN NORMAL AND MALIGNANT SIGNAL TRANSDUCTIONR29CA078629 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI VAN DER GEER, PETER · 1998 to 2002
$330k
NCI NIH HHS R01 CA078629NCI NIH HHS R01 CA78629NCI NIH HHS R29 CA078629NIA NIH HHS R01 AG025343
6 · The paper itself

Abstract

The CSF-1 receptor is a protein-tyrosine kinase that regulates the renewal, differentiation and activation of monocytes and macrophages. We have recently shown that the CSF-1 receptor undergoes regulated intramembrane proteolysis, or RIPping. Here, we report that RIPping can be observed in response to pathogen-associated molecules, which act through Toll-like receptors (TLRs). TLR-induced CSF-1 receptor RIPping is largely independent of protein kinase C, while maximal RIPping depends on Erk activation. Our studies show that CSF-1 receptor RIPping can be activated by various intracellular signal transduction pathways and that RIPping is likely to play an important role during macrophage activation.

Indexed as

Macrophage ActivationADAM17 ProteinADAM ProteinsAnimalsCell LineCell MembraneEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansLipopolysaccharidesMiceReceptor, Macrophage Colony-Stimulating FactorSignal TransductionToll-Like ReceptorsADAM17 ProteinADAM ProteinsExtracellular Signal-Regulated MAP KinasesLipopolysaccharidesReceptor, Macrophage Colony-Stimulating FactorToll-Like Receptors

Identifiers

PMID18294963
PMCPMC2276177
OpenAlexW1999272427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.